🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 33% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

2 VeganCap(s)(TM) Serving Size
30 Servings
Other Combinations Product Type
33% Evidence Coverage

Supplement Facts — Evidence Check

Calories
4 Calorie(s)
Total Carbohydrate
1 Gram(s) (1% DV)
Iron
0.6 mg (4% DV)
25 mcg (17% DV)
✅ Within RDA (0.2× RDA of 0.15 mg) 📚 243 studies (Tier A: 4, B: 133)
RDA 0.15mg This product: 0.025mg UL 1.1mg
Whole Food Blend with Prebiotic Ingredients
800 mg
📊 Market median: 80.0mg (20 products) 📚 334 studies (Tier A: 8, B: 183)
This product: 200mg

Other Ingredients

Rice Tapioca, Fermented

Label Claims — Verification

All Other
Structure/Function
All Other (98% of products) Structure/Function (74% of products) Nutrient (53% of products)

Target Groups

Vegan Vegetarian Adult (18 - 50 Years) Kosher Gluten Free Dairy Free

Product Information

📋 Directions for Use

Suggested use: Two capsules per day with or without food, taken at least 2 hours before or after antibiotics/fungals, or as advised by a qualified health care professional.

🧪 Formulation Notes

Friendly Force is a unique formula that combines 13 beneficial probiotic bacteria with functional whole foods containing prebiotic ingredients.

Friendly Force The ultimate probiotic 13 shelf stable strains 50 billion minimum CFU at time of manufacture

Digestive + Immune + Microbiome support

Certified Vegan Vegan.org

GFCO.org (Gluten Free Certification Organization)

OU Pareve (Kosher)

Additional Information

Up to 40 billion CFU until expiry date if stored as recommended. Store in a cool, dry place at or below 77 degrees F (25 degrees C). For maximum potency, keep refrigerated.

Certified Vegan Vegan.org GFCO.org (Gluten Free Certification Organization) OU Pareve (Kosher)

Product Details

UPC / SKU 6 50786 00416 9
DSLD Entry Date 2023-09-25
Product Type Other Combinations
Form Capsule
DSLD ID 293433
Data Updated 2026-04-11

Research Evidence

292 Research Sources
57 Avg Quality Score
160 Meta Analysis
70 Systematic Review
36 Rct
8 Cochrane Review
8 Clinical Trial
3 Regulatory Source
2 Narrative Review
2 Other
1 Guideline
1 Openfda Safety
A Umbilical cord antiseptics for preventing sepsis and death among newborns
Meta Analysis The Cochrane database of systematic reviews 2026
A Food fortification with multiple micronutrients: impact on health outcomes in general population
Meta Analysis The Cochrane database of systematic reviews 2019
A Interventions for cutaneous molluscum contagiosum
Meta Analysis The Cochrane database of systematic reviews 2017
A Chlorhexidine vs Povidone-Iodine and Incidence of Catheter-Related Infections: A Systematic Review and Meta-Analysis
Meta Analysis JAMA network open 2026
B Radioiodine Remnant Ablation for Differentiated Thyroid Cancer: A Systematic Review and Meta-analysis
Meta Analysis JAMA otolaryngology-- head & neck surgery 2021
B Risk of primary breast cancer in patients with differentiated thyroid cancer undergoing radioactive iodine therapy: a systematic review and meta-analysis
Meta Analysis European journal of nuclear medicine and molecular imaging 2022
B Alcoholic chlorhexidine skin preparation or triclosan-coated sutures to reduce surgical site infection: a systematic review and meta-analysis of high-quality randomised controlled trials
Meta Analysis The Lancet. Infectious diseases 2022
B Oral hygiene care for critically ill patients to prevent ventilator-associated pneumonia
Meta Analysis The Cochrane database of systematic reviews 2013
B Interventions for ingrowing toenails
Meta Analysis The Cochrane database of systematic reviews 2012
B Interventions for the management of malignant pleural effusions: a network meta-analysis
Systematic Review The Cochrane database of systematic reviews 2016
View all evidence for Iodine →

Compare Similar Products

View all Iodine products →